Project 3
项目3
基本信息
- 批准号:10615224
- 负责人:
- 金额:$ 24.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdolescenceAdverse eventAffectAlgorithmsAreaAttitudeBehaviorCaringCategoriesCause of DeathCessation of lifeClinicalDataData ScienceDetectionDiscriminationDisparityDoseEffectivenessEmergency department visitEnhancement TechnologyEthnic OriginEventExposure toFamilyFeeling suicidalFinancial HardshipFoodFriendsGoalsHealth StatusHospitalizationHousingIndividualInterventionKnowledgeLatinxLeadLife StressLos AngelesLow incomeMediatingMedicalMental DepressionMental HealthMethodsModelingOutcomePhasePopulationPreventionProtocols documentationRaceRandomizedResearchRiskRisk FactorsRisk ManagementSafetySamplingScienceSecuritySelf-Injurious BehaviorSeriesServicesSeveritiesSiteSocial supportStressStudent SelectionsStudentsSuicideSuicide attemptSuicide preventionSymptomsTestingTheoretical modelTimeTriageUnderrepresented MinorityUnited StatesUpdateWorkadaptive interventionanxiety treatmentclinical carecollegecommunity collegedigital interventionearly life adversityeffectiveness evaluationemerging adultevidence basegroup interventionhigh riskideationimprovedindexingintervention effectmobile computingnon-suicidal self injuryprediction algorithmpredictive modelingpreventive interventionprimary outcomeprognostic algorithmprognostic modelprotective factorsprototyperapid detectionreducing suiciderisk predictionscreeningsecondary outcomeskillssocial determinantsstandard of caresubstance usesuicidalsuicidal behaviorsuicidal individualsuicidal morbiditysuicidal risksuicide modeltreatment centertreatment responseyoung adult
项目摘要
Project 3 Abstract
The overall Project 3 goal is to advance science and clinical care for preventing suicide and self-harm and
strengthen knowledge for reaching our national objectives of reducing suicide deaths and attempts.22 Within the
context of the Center treatment model, “Screening and Treatment for Anxiety and Depression” (STAND), Project
3 extends the clinical targets of STAND to reducing suicide and self-harm risk with the goals of enhancing STAND
effectiveness and benefits, and offering a scalable suicide/self-harm prevention model for community colleges.
Recognizing disparities in mental health outcomes and access to evidence-based care, we focus on East Los
Angeles Community College (ELAC), a community college site in a diverse, low-income area in Los Angeles.
Using the Signature Project sample (N=1000) and methods, Project 3 seeks to: 1) enhance risk detection through
developing/evaluating algorithms for identifying indicators of “SU/SH risk states” that emerge prior to the onset
of suicidal/self-harm (SU/SH) behavior, and provide opportunities to deliver “just-in-time” interventions to prevent
suicidal/self-harm episodes; 2) evaluate the effectiveness of STAND with treatment tier/level assigned and
adapted based on data-driven algorithms, as compared to symptom severity, on suicide/self-harm outcomes;
and 3) enhance the effectiveness of STAND for suicide/self-harm prevention by augmenting STAND with a
technology-enhanced suicide prevention intervention (TE-SPI) that combines intervention components with
demonstrated benefits in prior research. These include: safety planning; a digital intervention (BRITE app) that
prompts safety plan use, skills, and hope; and caring contacts. The TE-SPI will be pre-tested and adapted for
the Center population during Years 1 & 2, providing data on safety, feasibility, acceptability, and intervention
effects. In Years 3-5, 420 students selected for need (STAND Tiers III or II) will be randomly assigned to either
the TE-SPI plus STAND with Usual Risk Management (URM), or STAND with URM. We test the hypothesis that
the TE-SPI group, relative to URM, will show: increased treatment engagement/contacts (i.e. app, STAND);
lower risk of suicide/self-harm events; greater improvement in severity of suicidality; lower levels of suicide/self-
harm related adverse events (e.g. hospitalizations, ED visits); and that increased treatment engagement leads
to improved suicide/self-harm outcomes. Primary and secondary outcomes respectively are: suicide/self-harm
events (including suicide attempts, unclear and nonsuicidal self-harm/NSSI); and an ordinal suicidality scale with
categories of none, ideation, intent/plan, suicidal behavior, suicide attempts.
项目3
项目3的总体目标是推进预防自杀和自残的科学和临床护理,
加强知识,以实现我们减少自杀死亡和自杀的国家目标。
中心治疗模式的背景下,“焦虑和抑郁症的筛查和治疗”(STAND),项目
3扩展了STAND的临床目标,以降低自杀和自我伤害风险,
有效性和益处,并为社区学院提供可扩展的自杀/自我伤害预防模型。
认识到心理健康结果和循证护理的差异,我们专注于东洛杉矶
洛杉矶社区学院(ELAC),一所社区学院,位于洛杉矶一个多元化的低收入地区。
使用签名项目样本(N=1000)和方法,项目3旨在:1)通过以下方式加强风险检测
开发/评估算法,用于识别发病前出现的“SU/SH风险状态”指标
自杀/自我伤害(SU/SH)行为,并提供机会提供“及时”干预,以防止
自杀/自我伤害事件; 2)评价STAND与分配的治疗等级/水平的有效性,
根据数据驱动的算法,与症状严重程度相比,根据自杀/自我伤害结果进行调整;
以及3)通过在STAND中增加
技术增强的自杀预防干预(TE-SPI),将干预成分与
在先前的研究中证明了这些好处。这些措施包括:安全规划;数字干预(BRITE应用程序),
提示安全计划的使用、技能和希望;以及关怀联系人。将对TE-SPI进行预测试和调整,
第1年和第2年的中心人群,提供安全性、可行性、可接受性和干预性数据
方面的影响.在3-5年级,420名学生根据需要(STAND Tiers III或II)被随机分配到
TE-SPI加STAND与商业风险管理(URM),或STAND与URM。我们检验了一个假设,
相对于URM,TE-SPI组将显示:增加的治疗参与/联系(即app、STAND);
自杀/自我伤害事件的风险较低;自杀严重程度改善较大;自杀/自我伤害水平较低,
伤害相关不良事件(例如住院、艾德访视);以及治疗参与度增加导致
改善自杀/自残的结果。主要和次要结局分别为:自杀/自残
事件(包括自杀企图、不明确和非自杀性自我伤害/NSSI);以及顺序自杀量表,
无、意念、意图/计划、自杀行为、自杀企图的类别。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joan Rosenbaum Asarnow其他文献
Coping and stress in families of child psychiatric inpatients: Parents of children with depressive and schizophrenia spectrum disorders
儿童精神科住院患者家庭的应对和压力:患有抑郁症和精神分裂症谱系障碍的儿童的父母
- DOI:
10.1007/bf00706122 - 发表时间:
1990 - 期刊:
- 影响因子:2.9
- 作者:
Joan Rosenbaum Asarnow;Amy Horton - 通讯作者:
Amy Horton
Joan Rosenbaum Asarnow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joan Rosenbaum Asarnow', 18)}}的其他基金
Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults
青少年和年轻人预防自杀的阶梯式护理的随机试验
- 批准号:
10468491 - 财政年份:2021
- 资助金额:
$ 24.91万 - 项目类别:
Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults
青少年和年轻人预防自杀的阶梯式护理的随机试验
- 批准号:
9750801 - 财政年份:2016
- 资助金额:
$ 24.91万 - 项目类别:
Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults
青少年和年轻人预防自杀的阶梯式护理的随机试验
- 批准号:
9553936 - 财政年份:2016
- 资助金额:
$ 24.91万 - 项目类别:
Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults
青少年和年轻人预防自杀的阶梯式护理的随机试验
- 批准号:
10002299 - 财政年份:2016
- 资助金额:
$ 24.91万 - 项目类别:
2_2 Treatment of Suicidal and Self_Injurous Adolescents with Emotional Dysregula
2_2 情绪失调的自杀和自残青少年的治疗
- 批准号:
8924875 - 财政年份:2011
- 资助金额:
$ 24.91万 - 项目类别:
2/2-Treatment of Suicidal and Self-Injurious Adolescents with Emotional Dysregula
2/2-情绪失调的自杀和自残青少年的治疗
- 批准号:
8110097 - 财政年份:2011
- 资助金额:
$ 24.91万 - 项目类别:
2/2-Treatment of Suicidal and Self-Injurious Adolescents with Emotional Dysregula
2/2-情绪失调的自杀和自残青少年的治疗
- 批准号:
8435464 - 财政年份:2011
- 资助金额:
$ 24.91万 - 项目类别:
2/2-Treatment of Suicidal and Self-Injurious Adolescents with Emotional Dysregula
2/2-情绪失调的自杀和自残青少年的治疗
- 批准号:
8248711 - 财政年份:2011
- 资助金额:
$ 24.91万 - 项目类别:
2/2-Evaluation of Family Focused Treatment for Childhood Depression
2/2-以家庭为中心的儿童抑郁症治疗评估
- 批准号:
8069600 - 财政年份:2009
- 资助金额:
$ 24.91万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 24.91万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 24.91万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 24.91万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 24.91万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 24.91万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 24.91万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 24.91万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 24.91万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 24.91万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 24.91万 - 项目类别: